| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/35228013_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/35228013_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/35228013_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/35228013_HAS_TOPIC_C5383286> <https://research.tib.eu/covid-19/entity/35228013_HAS_TOPIC_C5383287> <https://research.tib.eu/covid-19/entity/35228013_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/35228013_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/35228013_HAS_TOPIC_C5432330>
?:authorAffiliation	[\'Nuffield Department of Medicine, The Jenner Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom. Electronic address: alex.spencer@ndm.ox.ac.uk.\', \'Nuffield Department of Medicine, The Jenner Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom.\', \'Nuffield Department of Medicine, The Jenner Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom; The Pirbright Institute, Woking, Surrey, United Kingdom.\', \'The Pirbright Institute, Woking, Surrey, United Kingdom.\', \'The Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, United Kingdom; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, United Kingdom.\', \'The Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, United Kingdom.\', \'Department of Infectious Disease, Imperial College London, United Kingdom.\', \'Virology and Vaccine Discovery, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD United States.\', \'Nuffield Department of Medicine, The Jenner Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, United Kingdom.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Allen_Elizabeth_R> <https://research.tib.eu/covid-19/entity/Bailey_Dalan> <https://research.tib.eu/covid-19/entity/Barclay_Wendy_S> <https://research.tib.eu/covid-19/entity/Bissett_Cameron> <https://research.tib.eu/covid-19/entity/Bright_Helen> <https://research.tib.eu/covid-19/entity/Davies_Hannah> <https://research.tib.eu/covid-19/entity/Dejnirattisai_Wanwisa> <https://research.tib.eu/covid-19/entity/Donnellan_Francesca_R> <https://research.tib.eu/covid-19/entity/Gilbert_Sarah_C> <https://research.tib.eu/covid-19/entity/Kailath_Reshma> <https://research.tib.eu/covid-19/entity/Lambe_Teresa> <https://research.tib.eu/covid-19/entity/Liu_Chang> <https://research.tib.eu/covid-19/entity/McTamney_Patrick> <https://research.tib.eu/covid-19/entity/Mongkolsapaya_Juthathip> <https://research.tib.eu/covid-19/entity/Morris_Susan> <https://research.tib.eu/covid-19/entity/Newman_Joseph> <https://research.tib.eu/covid-19/entity/Peacock_Thomas_P> <https://research.tib.eu/covid-19/entity/Powers_Claire> <https://research.tib.eu/covid-19/entity/Pulido_David> <https://research.tib.eu/covid-19/entity/Ren_Kuishu> <https://research.tib.eu/covid-19/entity/Rudiansyah_Indra> <https://research.tib.eu/covid-19/entity/Screaton_Gavin> <https://research.tib.eu/covid-19/entity/Spencer_Alexandra_J> <https://research.tib.eu/covid-19/entity/Thakur_Nazia> <https://research.tib.eu/covid-19/entity/Truby_Adam> <https://research.tib.eu/covid-19/entity/Ulaszewska_Marta>
?:doi	S2352-3964(22)00086-X10.1016/j.ebiom.2022.103902
?:doi	<https://research.tib.eu/covid-19/entity/S2352-3964%2822%2900086-X10.1016/j.ebiom.2022.103902>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	EBioMedicine
is ?:pmid of	<https://research.tib.eu/covid-19/entity/35228013>
?:pmid	<https://research.tib.eu/covid-19/entity/35228013>
?:pmid	35228013
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	2.895
?:rankingScore_hIndex	26
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0042210_AUGMENTS_C0020964>
?:title	The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Nuffield Department of Medicine, The Jenner Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom. Electronic address: alex.spencer@ndm.ox.ac.uk.\', \'Nuffield Department of Medicine, The Jenner Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom.\', \'Nuffield Department of Medicine, The Jenner Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom; The Pirbright Institute, Woking, Surrey, United Kingdom.\', \'The Pirbright Institute, Woking, Surrey, United Kingdom.\', \'The Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, United Kingdom; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, United Kingdom.\', \'The Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, United Kingdom.\', \'Department of Infectious Disease, Imperial College London, United Kingdom.\', \'Virology and Vaccine Discovery, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD United States.\', \'Nuffield Department of Medicine, The Jenner Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, United Kingdom.\']

?:citedBy

-1

?:creator

?:doi

S2352-3964(22)00086-X10.1016/j.ebiom.2022.103902

?:doi

<https://research.tib.eu/covid-19/entity/S2352-3964%2822%2900086-X10.1016/j.ebiom.2022.103902>

?:hasPublicationType

<https://research.tib.eu/covid-19/entity/Journal_Article>

?:journal

EBioMedicine

is ?:pmid of

<https://research.tib.eu/covid-19/entity/35228013>

?:pmid

<https://research.tib.eu/covid-19/entity/35228013>

?:pmid

35228013

?:publication_isRelatedTo_Disease

<https://research.tib.eu/covid-19/entity/Covid-19>

?:rankingScore_SJR

2.895

?:rankingScore_hIndex

is ?:relation_isRelatedTo_publication of

<https://research.tib.eu/covid-19/entity/C0042210_AUGMENTS_C0020964>

?:title

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies.

?:type

?:year

2022

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/35228013>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/35228013>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

Metadata